Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen

Clinical Handbook of Psychotropic Drugs

Produktinformationen "Clinical Handbook of Psychotropic Drugs"

To the CHPD Patient Information Sheets

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

  • Independent, unbiased
  • Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
  • Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
  • Potential interactions and side effects summarized in comparison charts
  • With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
  • Clearly written patient information sheets available for download as printable PDF files
New in this edition:
  • Third-generation antipsychotics with major additions and changes
  • Pharmacogenomics fully revised
  • ECT thoroughly revised and updated
  • BLT / rTMS with extended references
  • Extrapyramidal side effects chart extended
  • Antidepressants vilazodone and vortioxetine with extended coverage
  • Updated chart for switching antidepressants
  • New chart of agents under investigation for treatment of substance use disorders
  • Approved and off-label indications updated
  • New unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depression, dementia, schizophrenia, and anxiety disorders
  • New agents include: TGAs N-arylpiperazine (brexpiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vraylar), hypnotic suvorexant (Belsomra)
  • New formulations and trade names include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quillivant XR

This book is a must for everyone who needs an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.

]]
product_form: BUCH

0 von 0 Bewertungen

Durchschnittliche Bewertung von 0 von 5 Sternen

Bewerten Sie dieses Produkt!

Teilen Sie Ihre Erfahrungen mit anderen Kunden.


Produktgalerie überspringen

Products Grouped by Project Tag GROUP_600496_M

Clinical Handbook of Psychotropic Drugs
product_form: BUCH
To the CHPD Patient Information SheetsThe Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.Independent, unbiasedPacked with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment optionsSuccinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drugPotential interactions and side effects summarized in comparison chartsWith instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seekClearly written patient information sheets available for download as printable PDF filesNew in this edition:Third-generation antipsychotics with major additions and changesPharmacogenomics fully revisedECT thoroughly revised and updatedBLT / rTMS with extended referencesExtrapyramidal side effects chart extendedAntidepressants vilazodone and vortioxetine with extended coverageUpdated chart for switching antidepressantsNew chart of agents under investigation for treatment of substance use disordersApproved and off-label indications updatedNew unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depression, dementia, schizophrenia, and anxiety disordersNew agents include: TGAs N-arylpiperazine (brexpiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vraylar), hypnotic suvorexant (Belsomra) New formulations and trade names include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quillivant XRThis book is a must for everyone who needs an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.]]

1.000.000,00 €*
Clinical Handbook of Psychotropic Drugs
To the CHPD Patient Information SheetsThe Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.Independent, unbiasedPacked with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment optionsSuccinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drugPotential interactions and side effects summarized in comparison chartsWith instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seekClearly written patient information sheets available for download as printable PDF filesNew in this edition:Third-generation antipsychotics with major additions and changesPharmacogenomics fully revisedECT thoroughly revised and updatedBLT / rTMS with extended referencesExtrapyramidal side effects chart extendedAntidepressants vilazodone and vortioxetine with extended coverageUpdated chart for switching antidepressantsNew chart of agents under investigation for treatment of substance use disordersApproved and off-label indications updatedNew unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depression, dementia, schizophrenia, and anxiety disordersNew agents include: TGAs N-arylpiperazine (brexpiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vraylar), hypnotic suvorexant (Belsomra) New formulations and trade names include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quillivant XRThis book is a must for everyone who needs an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.]]

74,72 €*